{"id":"W3217096783","doi":"10.1182/blood-2021-151648","title":"Phase II Study of Cladribine, Idarubicin, Cytarabine (CLIA) Plus Gilteritinib in Patients with FLT3 Mutated Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Idarubicin; Cytarabine; Cladribine; Medicine; Internal medicine; Concomitant; Gastroenterology; Fludarabine; Chemotherapy; Regimen; Surgery; Cyclophosphamide","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001066572,0.001297614,0.002023784,0.0003000225,0.0004047777,0.0008618975,0.0007465282,0.0008633301,0.002954521],"category_scores_gemma":[0.0006049685,0.0005549346,0.001099269,0.0003240334,0.0008568926,0.0005953409,0.0003371319,0.002587588,0.0008266494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000968386,"about_ca_system_score_gemma":0.001688094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001178241,"about_ca_topic_score_gemma":0.00243417,"domain_scores_codex":[0.999624,0.0001469275,0.00001872496,0.00009261369,0.00003033278,0.00008734179],"domain_scores_gemma":[0.9992828,0.00008104647,0.00007935521,0.00006069128,0.00003960266,0.0004566566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6867965,0.162464,0.01476996,0.0007051472,0.001385086,0.0005149595,0.0005344577,0.003197998,0.06243151,0.0002744116,0.003016133,0.06390984],"study_design_scores_gemma":[0.405201,0.5627865,0.02353212,0.00002450135,0.0004620875,0.0003705314,0.00008380401,0.001303042,0.00340199,0.00009955265,0.002706524,0.0000282531],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964637,0.0007178384,0.0002285814,0.0001470466,0.00007435879,0.001247032,0.0004332157,0.00003636307,0.000651947],"genre_scores_gemma":[0.9940209,0.0007170811,0.0007718228,0.0003876587,0.0001384418,0.001338763,0.001367342,0.00001498528,0.00124305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002954521,"threshold_uncertainty_score":0.009883821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01629800285645637,"score_gpt":0.2920428672431734,"score_spread":0.275744864386717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}